In landmark FDA tobacco study, e-cig questions likely to linger

businessinsider.com – 25 de Febrero de 2015 – EEUU
By Toni Clarke

(Reuters) - The U.S. Food and Drug Administration is poised to release initial data from a landmark study into how Americans use tobacco products, but researchers expect many key questions about e-cigarettes to remain unanswered.

The five-year Population Assessment of Tobacco and Health (PATH) Study of about 46,000 people, begun in 2011, is expected to provide a wealth of data about smoking behavior that could shape regulations ranging from warning labels and advertising restrictions to new product approvals.

"It is going to provide the most fine-grain, comprehensive, highest quality data on tobacco use that has ever been collected in the United States," said Stanton Glantz, a tobacco control expert at the University of California, San Francisco.

The FDA gained authority under a 2009 law to regulate cigarettes, smokeless tobacco and roll-your-own tobacco. It must issue new rules before it has authority to regulate e-cigarettes, cigars, hookahs and water pipes, among others. It has issued a draft proposal and is currently reviewing public comment before releasing final rules.

Publicación original:
See more at:

http://www.businessinsider.com/r-in-landmark-fda-tobacco-study-e-cig-questions-likely-to-linger-2015-2